Eye Drop

MARCO ISLAND, Fla. — Press coverage after approval and direct-to-consumer advertising significantly raised public interest in pilocarpine drops for presbyopia, according to a poster presented at the Women in Ophthalmology Summer Symposium.

The FDA has issued a warning to consumers not to purchase and to immediately stop use of Dr. Berne’s MSM Drops 5% Solution and LightEyez MSM Eye Drops because of bacterial and fungal contamination.

Using 0.05% atropine eyedrops every night for 2 years reduced the incidence of myopia in young children, although researchers acknowledge further study is needed.

OCS-01 eye drops demonstrated positive topline results for the treatment of inflammation and pain after cataract surgery, according to a press release from Oculis.

Harrow announced it will begin marketing and selling Vigamox, a fluoroquinolone antibiotic eye drop for bacterial conjunctivitis, following completion of the product’s new drug application transfer.

Visiox Pharma has entered into a definitive agreement with Santen Pharmaceutical to license product manufacturing and commercialization rights for Omlonti in the U.S., according to a press release.

OcuTerra Therapeutics completed enrollment in the phase 2 DR:EAM clinical trial, which is investigating OTT166 eye drops for the treatment of diabetic retinopathy, according to a press release.

WASHINGTON — NOV03 met endpoints specific to ocular burning and itching as well as corneal staining in patients with dry eye at 57 days and 15 weeks, Ahmad M. Fahmy, OD, FAAO, Dipl ABO, said in this Healio video from Optometry’s Meeting.

An affiliate of Bausch + Lomb acquired the over-the-counter Blink product line of eye and contact lens drops from Johnson & Johnson Vision, according to a press release.

In this Healio Video Perspective from the ASCRS meeting, Alison D. Early, MD, ABO, discusses a study that investigated the accuracy of self-administered eye drops in a real-world patient population.